Brief Summary
The RSSearch® Registry is an international multi-year database designed to track SRS/SBRT (Stereotactic Radiosurgery/Stereotactic Body Radiation Therapy) utilization, treatment practices and outcomes to help determine, over time, the most effective use of these systems in management of patients with life threatening tumors and other diseases. (This study was formally called ReCKord and included the CyberKnife only; The ReCKord study continues as a CyberKnife subset of RSSearch.)
Brief Title
RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT
Detailed Description
The Registry is designed to help SRS/SBRT (Stereotactic Radiosurgery/Stereotactic Body Radiation Therapy) users to understand utilization of and key treatment outcomes for these treatment approaches. Some of the objectives include:
Allow participants to record information about usage of SRS/SBRT in everyday practice, including patient characteristics and disease information, treatment plans and outcomes Provide participants with ready access to data for publication of their own experience and as a tool for establishing collaborations with other participating sites Facilitate quality improvement efforts for individual treatment providers Understand the effectiveness of different treatment plans for different types of lesions, diseases and treatments
The Registry tracks select outcomes for each condition treated by SRS/SBRT (for example, PSA for prostate cancer); the Registry also provides individual participants the ability to add additional outcomes for each and any condition of specific interest to their institutions.
The Registry is hosted by Vision Tree, Inc who is an independent vendor of electronic registries; they are responsible for HIPAA compliance, including all security mechanisms.
Patients will be enrolled prospectively. Some retrospective patient data is likely to be included in order to capture both short and longer term outcomes data.
Allow participants to record information about usage of SRS/SBRT in everyday practice, including patient characteristics and disease information, treatment plans and outcomes Provide participants with ready access to data for publication of their own experience and as a tool for establishing collaborations with other participating sites Facilitate quality improvement efforts for individual treatment providers Understand the effectiveness of different treatment plans for different types of lesions, diseases and treatments
The Registry tracks select outcomes for each condition treated by SRS/SBRT (for example, PSA for prostate cancer); the Registry also provides individual participants the ability to add additional outcomes for each and any condition of specific interest to their institutions.
The Registry is hosted by Vision Tree, Inc who is an independent vendor of electronic registries; they are responsible for HIPAA compliance, including all security mechanisms.
Patients will be enrolled prospectively. Some retrospective patient data is likely to be included in order to capture both short and longer term outcomes data.
Categories
Central Contacts
Central Contact Role
Contact
Central Contact Email
jjenkins@therss.org
Central Contact Role
Contact
Central Contact Email
jdavis@therss.org
Completion Date
Completion Date Type
Estimated
Conditions
Neoplasms
Arteriovenous Malformation of Central Nervous System
Trigeminal Neuralgia
Eligibility Criteria
Inclusion Criteria:
* Diagnosis of benign or malignant tumors or other conditions deemed treatable by stereotactic radiosurgery or stereotactic body radiotherapy
* Willingness to sign an Informed Consent Document or verbally agree to participation
Exclusion Criteria:
* There are no specific exclusion criteria, but patients who are unwilling to sign the ICD or who decline participation will not be included
* Diagnosis of benign or malignant tumors or other conditions deemed treatable by stereotactic radiosurgery or stereotactic body radiotherapy
* Willingness to sign an Informed Consent Document or verbally agree to participation
Exclusion Criteria:
* There are no specific exclusion criteria, but patients who are unwilling to sign the ICD or who decline participation will not be included
Inclusion Criteria
Inclusion Criteria:
* Diagnosis of benign or malignant tumors or other conditions deemed treatable by stereotactic radiosurgery or stereotactic body radiotherapy
* Willingness to sign an Informed Consent Document or verbally agree to participation
* Diagnosis of benign or malignant tumors or other conditions deemed treatable by stereotactic radiosurgery or stereotactic body radiotherapy
* Willingness to sign an Informed Consent Document or verbally agree to participation
Gender
All
Gender Based
false
Keywords
Radiosurgery
CyberKnife
Benign tumors
Malignant tumors
Cranial tumors
Extracranial tumors
Lung
Liver
Pancreas
Prostate
Stereotactic radiosurgery
Stereotactic body radiotherapy
Healthy Volunteers
No
Last Update Post Date
Last Update Post Date Type
Actual
Last Update Submit Date
NCT Id
NCT01885299
Org Class
Other
Org Full Name
The Radiosurgery Society
Org Study Id
RSSearch Patient Registry
Overall Status
Recruiting
Primary Completion Date
Primary Completion Date Type
Estimated
Official Title
Multi-Institution Registry of SRS/SBRT Procedures
Primary Outcomes
Outcome Description
Survival from time of treatment to death
Outcome Measure
Overall survival
Outcome Time Frame
Up to 5 years
Secondary Outcomes
Outcome Description
Calculated from time of treatment to recurrence
Outcome Time Frame
One to Five years
Outcome Measure
Local and distant recurrence
Start Date
Status Verified Date
First Post Date
First Post Date Type
Estimated
First Submit Date
First Submit QC Date
Study Population
Any patients who have a SRS/SBRT procedure
Std Ages
Child
Adult
Older Adult
Maximum Age Number (converted to Years and rounded down)
999
Minimum Age Number (converted to Years and rounded down)
0
Investigators
Investigator Type
Principal Investigator
Investigator Name
Madhur Garg
Investigator Email
mgarg@montefiore.org
Investigator Phone